1. Home
  2. ORMP vs CATO Comparison

ORMP vs CATO Comparison

Compare ORMP & CATO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORMP
  • CATO
  • Stock Information
  • Founded
  • ORMP 2002
  • CATO 1946
  • Country
  • ORMP United States
  • CATO United States
  • Employees
  • ORMP N/A
  • CATO N/A
  • Industry
  • ORMP Biotechnology: Pharmaceutical Preparations
  • CATO Clothing/Shoe/Accessory Stores
  • Sector
  • ORMP Health Care
  • CATO Consumer Discretionary
  • Exchange
  • ORMP Nasdaq
  • CATO Nasdaq
  • Market Cap
  • ORMP 91.9M
  • CATO 77.6M
  • IPO Year
  • ORMP N/A
  • CATO N/A
  • Fundamental
  • Price
  • ORMP $2.30
  • CATO $3.76
  • Analyst Decision
  • ORMP Hold
  • CATO
  • Analyst Count
  • ORMP 1
  • CATO 0
  • Target Price
  • ORMP N/A
  • CATO N/A
  • AVG Volume (30 Days)
  • ORMP 128.4K
  • CATO 106.8K
  • Earning Date
  • ORMP 03-05-2025
  • CATO 11-21-2024
  • Dividend Yield
  • ORMP N/A
  • CATO 14.01%
  • EPS Growth
  • ORMP N/A
  • CATO N/A
  • EPS
  • ORMP 0.11
  • CATO N/A
  • Revenue
  • ORMP N/A
  • CATO $666,779,000.00
  • Revenue This Year
  • ORMP N/A
  • CATO N/A
  • Revenue Next Year
  • ORMP N/A
  • CATO N/A
  • P/E Ratio
  • ORMP $20.65
  • CATO N/A
  • Revenue Growth
  • ORMP N/A
  • CATO N/A
  • 52 Week Low
  • ORMP $2.00
  • CATO $3.02
  • 52 Week High
  • ORMP $3.67
  • CATO $7.20
  • Technical
  • Relative Strength Index (RSI)
  • ORMP 41.44
  • CATO 48.89
  • Support Level
  • ORMP $2.37
  • CATO $3.36
  • Resistance Level
  • ORMP $2.36
  • CATO $3.93
  • Average True Range (ATR)
  • ORMP 0.06
  • CATO 0.24
  • MACD
  • ORMP -0.01
  • CATO 0.04
  • Stochastic Oscillator
  • ORMP 20.00
  • CATO 54.05

About ORMP Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.

About CATO Cato Corporation (The)

The Cato Corp operates as a specialty retailer of fashion apparel and accessories primarily in the southeastern United States. Its primary objective is to be the fashion specialty retailer for fashion and value in its markets. The company operates through the following business segments: Retail and Credit. The Retail segment which generates the majority of revenue offers fashion specialty stores. The Credit segment involves credit card services.

Share on Social Networks: